Prevention trials. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Organisms2

Vegetables HIV-1

Diseases31

HIV Infections Prostatic Neoplasms Adenomatous Polyps Colonic Polyps Adenoma Neoplasms Breast Neoplasms Stroke Sexually Transmitted Diseases Prostatic Hyperplasia Recurrence Coronary Disease Colorectal Neoplasms Neoplasm Recurrence, Local Cardiovascular Diseases HIV Seropositivity Obesity Hypercholesterolemia Myocardial Infarction Disease Progression Alzheimer Disease Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 1 Wounds and Injuries Chronic Disease Substance-Related Disorders Acute Disease Postoperative Complications Pregnancy Complications, Infectious Hypertension Disease Models, Animal

Chemicals and Drugs48

Finasteride 5-alpha Reductase Inhibitors Anticarcinogenic Agents Placebos Selenium Vaginal Creams, Foams, and Jellies Raloxifene Tamoxifen Selective Estrogen Receptor Modulators Naproxen Selenomethionine Vitamin E Fats, Unsaturated Estrogen Receptor Modulators Antineoplastic Agents, Hormonal Aspirin Prostate-Specific Antigen Azasteroids Flavonols Anti-HIV Agents beta Carotene alpha-Tocopherol Hydroxymethylglutaryl-CoA Reductase Inhibitors Antioxidants Fluorobenzenes Hypolipidemic Agents Vitamins Sulfonamides Pravastatin AIDS Vaccines Fenretinide Carotenoids Anti-Inflammatory Agents, Non-Steroidal Biological Markers Cholesterol Cholesterol, LDL Pyrazoles Enzyme Inhibitors Estrogens Dietary Fats Antineoplastic Agents Cholesterol, HDL Tumor Markers, Biological Anticoagulants Platelet Aggregation Inhibitors Drug Combinations Anti-Bacterial Agents Anti-Infective Agents, Local

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Clinical Trials as Topic Randomized Controlled Trials as Topic Research Design Double-Blind Method Risk Factors Patient Selection Digital Rectal Examination Placebos Treatment Outcome Clinical Trials, Phase III as Topic Chemoprevention Early Termination of Clinical Trials Multicenter Studies as Topic Follow-Up Studies Incidence Vaginal Creams, Foams, and Jellies Bibliotherapy Risk Assessment Prospective Studies Risk Sample Size Contraceptive Devices, Female Diet, Fat-Restricted Questionnaires Intervention Studies Mass Screening Logistic Models Cohort Studies Prevalence Administration, Intravaginal Clinical Trials, Phase II as Topic Pilot Projects Odds Ratio Controlled Clinical Trials as Topic Drug Therapy, Combination Clinical Trials, Phase I as Topic Models, Statistical Colonoscopy Longitudinal Studies Obesity Case-Control Studies Biopsy, Needle Predictive Value of Tests Data Interpretation, Statistical Severity of Illness Index Clinical Protocols Confidence Intervals Proportional Hazards Models Data Collection Single-Blind Method Sensitivity and Specificity Multivariate Analysis Cross-Sectional Studies Reproducibility of Results Prognosis Kaplan-Meier Estimate Biopsy Body Mass Index Program Evaluation Analysis of Variance Self Report Drug Administration Schedule Retrospective Studies Regression Analysis Administration, Oral Survival Analysis Feasibility Studies Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Random Allocation Clinical Trials, Phase IV as Topic Exercise Therapy Survival Rate Cross-Over Studies Population Surveillance Meta-Analysis as Topic Disease-Free Survival Interviews as Topic Infusions, Intravenous Condoms Chi-Square Distribution Quality-Adjusted Life Years Antibiotic Prophylaxis Phytotherapy Pain Measurement Disease Models, Animal Treatment Failure Cluster Analysis Circumcision, Male

Psychiatry and Psychology19

Risk Reduction Behavior Bibliotherapy Patient Compliance Health Knowledge, Attitudes, Practice Sexual Behavior Smoking Counseling Health Behavior Risk-Taking Homosexuality, Male Life Style Alcohol Drinking Alzheimer Disease Depression Cognitive Therapy Substance-Related Disorders Smoking Cessation Motivation Suicide

Phenomena and Processes15

Time Factors Risk Diet Diet, Fat-Restricted Odds Ratio Pregnancy Obesity Homosexuality, Male Exercise Sensitivity and Specificity Body Mass Index Postmenopause Dose-Response Relationship, Drug Algorithms Chi-Square Distribution

Disciplines and Occupations6

Research Design Biomedical Research Evidence-Based Medicine Preventive Medicine Outcome Assessment (Health Care)Public Health

Anthropology, Education, Sociology and Social Phenomena11

National Institute of Mental Health (U.S.)Centers for Disease Control and Prevention (U.S.)Health Education Schools Exercise Forecasting Quality of Life Patient Education as Topic Developing Countries Socioeconomic Factors Suicide

Technology, Industry, Agriculture6

Dietary Supplements Vitamins Vegetables Dietary Fiber Fruit Dietary Fats

Humanities1

Quality of Life

Information Science11

Incidence Questionnaires Prevalence Data Interpretation, Statistical Data Collection Self Report Algorithms Survival Rate Interviews as Topic Quality-Adjusted Life Years Internet

Named Groups4

Research Subjects African Americans Sexual Partners Infant, Newborn

Health Care100

Clinical Trials as Topic Primary Prevention Randomized Controlled Trials as Topic Secondary Prevention Double-Blind Method Risk Factors Patient Selection National Institute of Mental Health (U.S.)Treatment Outcome Clinical Trials, Phase III as Topic Early Termination of Clinical Trials Multicenter Studies as Topic Follow-Up Studies Incidence Risk Assessment Prospective Studies Risk Sample Size Centers for Disease Control and Prevention (U.S.)Health Promotion Questionnaires Health Education Patient Compliance Intervention Studies Mass Screening Logistic Models Health Knowledge, Attitudes, Practice Cohort Studies Cost-Benefit Analysis Prevalence Accident Prevention Age Factors Clinical Trials, Phase II as Topic Pilot Projects Odds Ratio Controlled Clinical Trials as Topic Counseling Clinical Trials, Phase I as Topic Infectious Disease Transmission, Vertical Models, Statistical Longitudinal Studies Practice Guidelines as Topic Bias (Epidemiology)Case-Control Studies Patient Participation Predictive Value of Tests Data Interpretation, Statistical Severity of Illness Index Clinical Protocols Confidence Intervals Proportional Hazards Models Confounding Factors (Epidemiology)Data Collection Single-Blind Method Sex Factors Sensitivity and Specificity Multivariate Analysis Cross-Sectional Studies Reproducibility of Results Kaplan-Meier Estimate Preventive Health Services Body Mass Index Program Evaluation Analysis of Variance Self Report Retrospective Studies Regression Analysis Clinical Trials Data Monitoring Committees Outcome Assessment (Health Care)Patient Education as Topic Survival Analysis Feasibility Studies Random Allocation Community Health Services Accidental Falls Clinical Trials, Phase IV as Topic School Health Services Program Development Public Health Intention to Treat Analysis Safety Survival Rate Cross-Over Studies Population Surveillance Meta-Analysis as Topic Disease-Free Survival Health Care Costs Interviews as Topic Primary Health Care Chi-Square Distribution Quality-Adjusted Life Years Tertiary Prevention Socioeconomic Factors Guideline Adherence Guidelines as Topic Placebo Effect Treatment Failure Cluster Analysis Patient Acceptance of Health Care Patient Satisfaction

Geographicals11

United States Zimbabwe South Africa Africa Thailand Peru Great Britain Netherlands Canada Europe Australia

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Finasteride Clinical Trials as Topic Primary Prevention Randomized Controlled Trials as Topic 5-alpha Reductase Inhibitors Research Design Secondary Prevention Double-Blind Method Risk Factors Patient Selection Anticarcinogenic Agents HIV Infections National Institute of Mental Health (U.S.)Digital Rectal Examination Prostatic Neoplasms Placebos Treatment Outcome Clinical Trials, Phase III as Topic Chemoprevention Adenomatous Polyps United States Colonic Polyps Early Termination of Clinical Trials Multicenter Studies as Topic Follow-Up Studies Selenium Incidence Risk Reduction Behavior Vaginal Creams, Foams, and Jellies Raloxifene Bibliotherapy Risk Assessment Tamoxifen Selective Estrogen Receptor Modulators Dietary Supplements Time Factors Adenoma Naproxen Prospective Studies Risk Sample Size Centers for Disease Control and Prevention (U.S.)Selenomethionine Diet Vitamin E Contraceptive Devices, Female Diet, Fat-Restricted Health Promotion Neoplasms Breast Neoplasms Fats, Unsaturated Questionnaires Research Subjects Health Education Zimbabwe Estrogen Receptor Modulators Patient Compliance Antineoplastic Agents, Hormonal Stroke Intervention Studies Mass Screening Aspirin Prostate-Specific Antigen Azasteroids Logistic Models South Africa Flavonols Health Knowledge, Attitudes, Practice Cohort Studies Cost-Benefit Analysis Sexually Transmitted Diseases Sexual Behavior Prostatic Hyperplasia Prevalence Accident Prevention Anti-HIV Agents Recurrence Coronary Disease Age Factors Administration, Intravaginal Clinical Trials, Phase II as Topic Pilot Projects Smoking Odds Ratio beta Carotene Controlled Clinical Trials as Topic Drug Therapy, Combination African Americans Pregnancy Counseling alpha-Tocopherol Hydroxymethylglutaryl-CoA Reductase Inhibitors Africa Colorectal Neoplasms Clinical Trials, Phase I as Topic Antioxidants Neoplasm Recurrence, Local Infectious Disease Transmission, Vertical Schools Models, Statistical

No FAQ available that match "prevention trials"